Evaxion A/S - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Evaxion A/S - ADR
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients’ lives by providing innovative and targeted treatment options.
/ 
Others were interested in
Frequently asked questions
To buy Evaxion A/S - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Evaxion A/S - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Evaxion A/S - ADR is EVAX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Evaxion A/S - ADR has its primary listing on NASDAQ (Small cap). You can trade Evaxion A/S - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Evaxion A/S - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Evaxion A/S - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Evaxion A/S - ADR.